Gralise Tablet, Film Coated
Product Images NDC 52427-850

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Gralise (NDC 52427-850). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Almatica Pharma Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

300mg-90s (300mg Label)

Label for Gralise (gabapentin) tablets 300 mg, a once-daily oral medication. The label includes directions to take with the evening meal and swallow whole without crushing, splitting, or chewing. It features storage instructions, warnings, and distributor information for Almatica Pharma LLC, Morristown, NJ. The package contains 90 tablets.*

FDA Label Image

600mg-90s (600mg Label)

Gralise 600 mg (gabapentin) tablets label, once-daily prescription medication distributed by Almatica Pharma LLC. The label highlights storage instructions, dosage direction to take with an evening meal, and a warning not to use interchangeably with other gabapentin products. The package contains 90 tablets and includes instructions for pharmacists to dispense the accompanying Medication Guide.*

FDA Label Image

Titration-pack (Blister Sample)

Gralise (gabapentin) tablets sample pack label by Almatica Pharma LLC, containing 9 tablets of 300 mg and 24 tablets of 600 mg. The label includes instructions for a 15-day dosing schedule with gradually increasing doses, a warning not to interchange with other gabapentin products, storage directions, and contact information for reporting side effects. The package is marked as a professional sample, not for resale.*

FDA Label Image

Figure-1 (Figure 1)

A line graph comparing the percent of patients improved over varying levels of percent improvement in pain from baseline. Two lines are shown: one for Gralise and one for placebo, with Gralise showing consistently higher patient improvement percentages across the pain relief spectrum.*

FDA Label Image

Structure (Structure)

Chemical structure diagram showing a cyclohexane ring with an amino group (CH2NH2) and a carboxylic acid group (CH2COOH) attached to the same carbon atom.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.